The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

researchresearch.com

Founded Year

1994

Stage

Acquired | Acquired

About *Research

*Resarch is a provider of research news and funding information for the academic research community.

*Research Headquarter Location

Unit 111, Curtain House 134-146 Curtain Road

London, England, EC2A 3AR,

United Kingdom

+44 20 7216 6500

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

*Research Patents

*Research has filed 1038 patents.

The 3 most popular patent topics include:

  • Chemical processes
  • Molecular biology
  • Transcription factors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/17/2019

5/17/2022

Clusters of differentiation, Immune system, Immunology, Monoclonal antibodies, Proteins

Grant

Application Date

9/17/2019

Grant Date

5/17/2022

Title

Related Topics

Clusters of differentiation, Immune system, Immunology, Monoclonal antibodies, Proteins

Status

Grant

  • When was *Research founded?

    *Research was founded in 1994.

  • Where is *Research's headquarters?

    *Research's headquarters is located at Unit 111, Curtain House, London.

  • What is *Research's latest funding round?

    *Research's latest funding round is Acquired.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.